OFFICE OF news communications
In The Spotlight
‘Medicine in the 21st Century’ Celebrates President Theobald’s Investiture
October 22, 2013
The presenters of ‘Medicine in the 21st Century’ (L to R): Crystal Gadegbeku, MD; Jonathan Chernoff, MD, PhD; T. Sloane Guy, MD, MBA; Howard Cohen, MD; Jay Rappaport, PhD; Nora Engel, PhD; and Joseph Cheung, MD, PhD.
On October 18, seven university-wide symposia addressing a kaleidoscope of topics celebrated the investiture of Temple University’s new president, Dr. Neil Theobald – and showcased collaborative and imaginative scholarship for which Temple is known.
Six nationally known faculty experts representing Temple Health teamed up to present “Medicine in the 21st Century,” a panoply of trends and theories shaping the way disease is–and will be– treated, at Temple and beyond.
“We gave a snapshot of the paradigm-changing research, next-generation technologies, and cross-specialty innovations that will move the field of medical science ahead,” said Joseph Cheung, MD, PhD, Senior Associate Dean for Research at Temple University School of Medicine, who moderated the symposium, held in Beury Hall on Temple’s main campus.
Nora Engel, PhD, Assistant Professor, Fels Institute for Cancer Research and Molecular Biology, described how cancer treatment could be revolutionized through the epigenetic modulation of the human genome.
The Director of Temple’s Interventional Heart and Vascular Institute, Howard Cohen, MD, Professor of Medicine, showcased new and emerging image-guided, catheter-based interventions already available at Temple to revolutionize heart valve repair.
Jay Rappaport, PhD, Associate Chairperson of the Department of Neuroscience and Professor of Neuroscience and Neurovirology, shared insights on the efforts to discover treatments for the ever-growing problem of AIDS-related dementia.
The Chief of Temple’s section of Nephrology, Crystal Gadegbeku, MD, Associate Professor of Medicine, shed light on novel molecular pathways that may one day lead to interventions to reduce excessive cardiovascular morbidity and mortality in patients with chronic kidney disease.
Jonathan Chernoff, MD, PhD, Fox Chase Cancer Center’s Chief Scientific Director and Stanley P. Reimann Chair in Oncology Research, explained current and next-generation techniques that researchers are developing to identify the “weaknesses” of cancer cells, with an eye toward developing new treatments and therapies.
T. Sloane Guy, MD, MBA, Chief of Cardiothoracic Surgery and Associate Professor of Surgery, previewed the mechanical hearts and robotic techniques at cardiac surgery’s frontier edge—all available at Temple.
Theobald, a former Indiana University administrator, became Temple's 10th president in January. His investiture was celebrated with a variety of educational, social and cultural events attended by faculty, staff, students, alumni and dignitaries such as Governor Corbett, City Council President Darrell L. Clarke, and the presidents of 13 areas colleges.
Follow us on:
Assistant Vice President
Department of Communications
Temple University Health System
3509 N. Broad St., 9th Floor
Philadelphia, PA 19140